Liontrust Investment Partners LLP Increases Stock Position in Astera Labs, Inc. $ALAB

Liontrust Investment Partners LLP grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 98.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 105,270 shares of the company’s stock after purchasing an additional 52,284 shares during the quarter. Liontrust Investment Partners LLP’s holdings in Astera Labs were worth $11,538,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Reflection Asset Management purchased a new stake in Astera Labs in the 4th quarter valued at approximately $25,000. Smartleaf Asset Management LLC raised its holdings in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in shares of Astera Labs in the fourth quarter worth $33,000. Wexford Capital LP acquired a new position in shares of Astera Labs in the third quarter worth $39,000. Finally, National Bank of Canada FI lifted its position in shares of Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Up 20.0%

Shares of NASDAQ:ALAB opened at $299.69 on Friday. The company has a market cap of $51.37 billion, a P/E ratio of 202.49, a P/E/G ratio of 2.89 and a beta of 3.66. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The business has a fifty day simple moving average of $359.89 and a 200-day simple moving average of $229.21.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same period in the prior year, the business posted $0.33 earnings per share. The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ALAB has been the topic of a number of analyst reports. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. JPMorgan Chase & Co. upped their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Stifel Nicolaus raised their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Morgan Stanley lifted their price target on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Finally, Barclays boosted their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Thirteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $282.00.

Insider Activity

In other news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the transaction, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,676,845 shares of company stock valued at $444,928,806 in the last 90 days. 10.40% of the stock is currently owned by insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.